BiotechTube
Home/Poxel/Thomas Kuhn
TK

Thomas Kuhn

Chief Executive Officer

Poxel

Therapeutic Areas

Non-alcoholic Steatohepatitis (NASH)Rare Metabolic DisordersType 2 Diabetes

Poxel Pipeline

DrugIndicationPhase
PXL065Non-alcoholic steatohepatitis (NASH)Phase 2
PXL770Rare Metabolic Diseases (e.g., ADPKD)Phase 2a
TWYMEEG (Imeglimin)Type 2 DiabetesMarketed

Leadership Team at Poxel

SB
Sébastien Bolze
Founder and Chairman of the Board
CB
Cécile Baudrier
Chief Financial Officer
DS
David S. Horn
Chief Medical Officer
View full Poxel profile